rs150780279
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001267571.2(TBC1D2):c.2179G>C(p.Glu727Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001267571.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152244Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000517 AC: 13AN: 251296 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461856Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727234 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74388 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2179G>C (p.E727Q) alteration is located in exon 10 (coding exon 10) of the TBC1D2 gene. This alteration results from a G to C substitution at nucleotide position 2179, causing the glutamic acid (E) at amino acid position 727 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at